Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial Open Access.
- Published in:
- Nephrology Dialysis Transplantation, 2025, v. 40, n. 7, p. 1332, doi. 10.1093/ndt/gfae273
- By:
- Publication type:
- Article
Works by Aarup, Michael
Results: 8
1
2
Clinical implications of converting stable haemodialysis patients from subcutaneous to intravenous administration of darbepoetin alfa.
- Published in:
- Nephrology Dialysis Transplantation, 2006, v. 21, n. 5, p. 1312, doi. 10.1093/ndt/gfk048
- By:
- Publication type:
- Article
3
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis.
- Published in:
- Clinical Kidney Journal, 2019, v. 12, n. 1, p. 139, doi. 10.1093/ckj/sfy014
- By:
- Publication type:
- Article
4
Dialysis for twins.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
5
Factors influencing access to education, decision making, and receipt of preferred dialysis modality in unplanned dialysis start patients.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 2229, doi. 10.2147/PPA.S119243
- By:
- Publication type:
- Article
6
Determinants of bone mineral density in patients on haemodialysis or peritoneal dialysis - a cross-sectional, longitudinal study.
- Published in:
- Biochemia Medica, 2013, v. 23, n. 3, p. 342, doi. 10.11613/BM.2013.042
- By:
- Publication type:
- Article
7
Offering Patients Therapy Options in Unplanned Start (OPTiONS): Implementation of an educational program is feasible and effective.
- Published in:
- 2017
- By:
- Publication type:
- journal article
8
Dialysis access, infections, and hospitalisations in unplanned dialysis start patients: results from the OPTiONS study.
- Published in:
- 2017
- By:
- Publication type:
- journal article